These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2332507)

  • 21. Multiple in vivo effects of interleukin-3 and interleukin-6 on murine megakaryocytopoiesis.
    Carrington PA; Hill RJ; Stenberg PE; Levin J; Corash L; Schreurs J; Baker G; Levin FC
    Blood; 1991 Jan; 77(1):34-41. PubMed ID: 1984801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of recombinant human Steel factor (c-kit ligand) on early cord blood hematopoietic precursors.
    Abboud MR; Xu F; Payne A; Laver J
    Exp Hematol; 1994 Apr; 22(4):388-92. PubMed ID: 7512047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
    Damia G; Komschlies KL; Futami H; Back T; Gruys ME; Longo DL; Keller JR; Ruscetti FW; Wiltrout RH
    Cancer Res; 1992 Aug; 52(15):4082-9. PubMed ID: 1638519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
    Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
    Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonistic effects of interleukin 6 and G-CSF in the later stage of human granulopoiesis in vitro.
    Katayama K; Koizumi S; Ueno Y; Ohno I; Ichihara T; Horita S; Miyawaki T; Taniguchi N
    Exp Hematol; 1990 Jun; 18(5):390-4. PubMed ID: 1692536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential administration of interleukin-6 and granulocyte-colony stimulating factor in newborn rats: modulation of newborn granulopoiesis and thrombopoiesis.
    Cairo MS; Plunkett JM; Nguyen A; Clark S; van de Ven C
    Pediatr Res; 1991 Dec; 30(6):554-9. PubMed ID: 1725208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow.
    Laterveer L; van Damme J; Willemze R; Fibbe WE
    Exp Hematol; 1993 Dec; 21(13):1621-7. PubMed ID: 8243564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model.
    Winton EF; Srinivasiah J; Kim BK; Hillyer CD; Strobert EA; Orkin JL; Swenson RB; McClure HM; Myers LA; Saral R
    Blood; 1994 Jul; 84(1):65-73. PubMed ID: 8018931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
    Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C
    Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of IL-1 receptor antagonist on the proliferation of hematopoietic progenitor cells in regenerating bone marrow.
    Jovcić G; Ivanović Z; Biljanović-Paunović L; Bugarski D; Stosić-Grujicić S; Milenković P
    Leukemia; 1996 Mar; 10(3):564-9. PubMed ID: 8642876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologic effects of recombinant human interleukin-3 in vivo.
    Lindemann A; Ganser A; Herrmann F; Frisch J; Seipelt G; Schulz G; Hoelzer D; Mertelsmann R
    J Clin Oncol; 1991 Dec; 9(12):2120-7. PubMed ID: 1960553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
    Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
    Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
    Cairo MS; Plunkett JM; Schendel P; van de Ven C
    Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal recovery of short-term repopulating HSC subpopulations in marrow following schedule-dependent administrations of IL-1 alpha and M-CSF.
    Kovacs CJ; Evans MJ; Roberts C; Harrell J; Abernathy R; Gooya J; Johnke RM
    Exp Hematol; 1995 Aug; 23(9):1016-23. PubMed ID: 7635181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
    Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP
    Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of rhIL-11 on normal dogs and after sublethal radiation.
    Nash RA; Seidel K; Storb R; Slichter S; Schuening FG; Appelbaum FR; Becker AB; Bolles L; Deeg HJ; Graham T
    Exp Hematol; 1995 May; 23(5):389-96. PubMed ID: 7720811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates.
    Mayer P; Geissler K; Valent P; Ceska M; Bettelheim P; Liehl E
    Exp Hematol; 1991 Aug; 19(7):688-96. PubMed ID: 1909969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.
    Futami H; Jansen R; MacPhee MJ; Keller J; McCormick K; Longo DL; Oppenheim JJ; Ruscetti FW; Wiltrout RH
    J Immunol; 1990 Dec; 145(12):4121-30. PubMed ID: 2258610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of interleukin-11 with and without granulocyte colony-stimulating factor on in vivo neonatal rat hematopoiesis: induction of neonatal thrombocytosis by interleukin-11 and synergistic enhancement of neutrophilia by interleukin-11 + granulocyte colony-stimulating factor.
    Cairo MS; Plunkett JM; Nguyen A; Schendel P; van de Ven C
    Pediatr Res; 1993 Jul; 34(1):56-61. PubMed ID: 7689197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.
    Biesma B; Willemse PH; Mulder NH; Sleijfer DT; Gietema JA; Mull R; Limburg PC; Bouma J; Vellenga E; de Vries EG
    Blood; 1992 Sep; 80(5):1141-8. PubMed ID: 1515636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.